-+ 0.00%
-+ 0.00%
-+ 0.00%

Uranium Royalty (UROY), Why Is It Back In The Spotlight?

Simply Wall St·08/10/2026 22:37:52
Listen to the news

Recent board changes at Uranium Royalty (NasdaqCM:UROY) have put governance in focus after a busy few weeks that also included fresh annual results, a new shelf registration, and a voluntary SEC deregistration.

See our latest analysis for Uranium Royalty.

Against this backdrop of board changes, annual results and new capital plans, Uranium Royalty’s share price has moved sharply in recent weeks, with a 30 day share price return of 50.18% and a 1 year total shareholder return of 60.70%, which suggests momentum has strengthened over the medium term despite some shorter term pullbacks.

If you are tracking how investor interest in uranium related stocks is evolving, it can be useful to see what else is moving across the sector with the 89 nuclear energy infrastructure stocks

After a 50.18% move in 30 days and a 60.70% total return over the past year, Uranium Royalty now sits at US$4.13, just above the latest analyst target. Is most of the upside now priced in, or not yet?

Price-to-Earnings of 39.1x: Is it justified?

On recent numbers, Uranium Royalty trades on a P/E of 39.1x at a share price of $4.13, which screens as expensive against both peers and the wider industry.

The P/E ratio compares what investors pay today for each dollar of current earnings. For a royalty and physical uranium holding company like Uranium Royalty, a higher P/E often reflects expectations that current profits are not the end point, especially after the shift from losses to profitability.

However, Uranium Royalty’s current P/E of 39.1x sits well above the peer group average of 26.1x and more than double the 18x average for the US Metals and Mining industry. That suggests the market is pricing in stronger earnings power than is implied by sector averages, even though there is insufficient forecast data here to show whether those expectations are supported.

See what the numbers say about this price — find out in our valuation breakdown.

Result: Price-to-Earnings of 39.1x (OVERVALUED)

However, the Uranium Royalty story could shift quickly if uranium sector sentiment cools, or if the rich P/E multiple compresses from current levels.

Find out about the key risks to this Uranium Royalty narrative.

Another view on Uranium Royalty’s value

The P/E of 39.1x already looks full for Uranium Royalty, yet the SWS DCF model is even more cautious. It values future cash flows at $0.89 per share, which is well below the current $4.13 price and indicates an overvalued stock on this method.

That is a wide gap between what the market is paying and what the SWS DCF model suggests. It raises a simple question for investors: Is the market overestimating future cash flows, or is the model missing something about Uranium Royalty’s uranium exposure and royalty portfolio potential?

Look into how the SWS DCF model arrives at its fair value.

UROY Discounted Cash Flow as at Aug 2026
UROY Discounted Cash Flow as at Aug 2026

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Uranium Royalty for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 52 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

Given the mix of optimism and concern around Uranium Royalty’s valuation and recent moves, it makes sense to review the data yourself while sentiment is still evolving. To see the balance of potential upside and risks in one place, review the 1 key reward and 1 important warning sign

Looking for more investment ideas beyond Uranium Royalty?

If Uranium Royalty has sharpened your focus on opportunities, do not stop here. Broaden your watchlist now so you are not late to the next setup.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.